PRIMARY STUDY
Increased expression of CB2 receptor in the intestinal biopsies of children with inflammatory bowel disease
Key Findings: This study of pediatric patients with inflammatory bowel disease (IBD) identified an upregulation of CB2 receptors, suggesting a potential therapeutic target for drug discovery.
Type of Study: Clinical Trial
Study Sample Size: 15
Study Result: Positive
Study Location(s): Italy
Year of Pub: 2022
Cannabinoids Studied: Endocannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB2
